1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Human Genome Sciences

Anonymous board for Human Genome Sciences


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    1
    Views:
    1,391
  2. Anonymous
    Replies:
    25
    Views:
    20,355
  3. Biotechblogger
    Replies:
    0
    Views:
    3,324
  4. Anonymous
    Replies:
    19
    Views:
    10,351
  5. Anonymous
    Replies:
    7
    Views:
    6,418
  6. Anonymous
    Replies:
    0
    Views:
    2,563
  7. Anonymous
    Replies:
    1
    Views:
    3,123
  8. Anonymous
    Replies:
    11
    Views:
    4,977
  9. Anonymous
    Replies:
    1
    Views:
    2,755
  10. Anonymous
    Replies:
    8
    Views:
    4,455
  11. Anonymous
    Replies:
    9
    Views:
    4,945
  12. Anonymous
    Replies:
    1
    Views:
    4,559
  13. Anonymous
    Replies:
    2
    Views:
    3,203
  14. Anonymous
    Replies:
    5
    Views:
    4,173
  15. Anonymous
    Replies:
    2
    Views:
    3,345
  16. Anonymous
    Replies:
    3
    Views:
    3,100
  17. Anonymous
    Replies:
    9
    Views:
    3,157
  18. Anonymous
    Replies:
    8
    Views:
    5,689

Thread Display Options

Loading...